https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-04-14 12:43:292016-11-28 12:43:51Astex Reports Positive Clinical Biomarker Data from its Phase I study on CDK Inhibitor AT7519 at the AACR Annual Meeting 2009
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-04-13 12:44:002016-11-28 12:44:26SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-04-07 12:44:452016-11-28 12:45:23SuperGen to Webcast 4th Annual Analyst Day on April 14, 2009
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-03-31 12:45:582016-11-28 12:46:24Astex Achieves Milestones in Drug Discovery Collaboration
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-03-24 12:46:352016-11-28 12:46:58Astex Awarded £2 Million from Wellcome Trust for Pioneering HCV Research
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-03-02 11:47:472016-11-28 12:48:13Astex Receives Award from the Multiple Myeloma Research Foundation to Support Clinical Development of AT7519
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-02-11 12:48:542016-11-28 12:49:23Astex and Cancer Research UK Collaborate on Clinical Studies of AT9283 in Childhood Cancers
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
